谷歌浏览器插件
订阅小程序
在清言上使用

Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health System

Clinical Lung Cancer(2023)

引用 3|浏览43
暂无评分
关键词
Chemoradiation,Durvalumab,Immunotherapy,PACIFIC
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要